Yichan Zhou,James Weiquan Li,Noriya Uedo
Yichan Zhou
The foregut, which includes the esophagus, stomach and duodenum, represents one of the most common sites for neuroendocrine neoplasms. These are highly heterogenous with different risk of progression depending on location, cell-type of orig...
Annemijn D I Maan,Prateek Sharma,Arjun D Koch
Annemijn D I Maan
The incidence of oesophageal adenocarcinoma has been increasing rapidly in the Western world. A well-known risk factor for developing this type of tumour is reflux disease, which can cause metaplasia from the squamous cell mucosa to columna...
Endoscopic resection for residual oesophageal neoplasia after definitive chemoradiotherapy [0.03%]
根治性化学免疫治疗或放疗后食管残余肿瘤的内镜下切除疗法
Judith Honing,Arjun D Koch,Peter D Siersema et al.
Judith Honing et al.
Definitive chemoradiation is the recommended treatment for locally advanced, irresectable oesophageal cancer and a valid alternative to neoadjuvant chemoradiotherapy (CRT) with surgery in oesophageal squamous cell cancer (OSCC) patients. In...
João A Cunha Neves,Pedro G Delgado-Guillena,Patrícia Queirós et al.
João A Cunha Neves et al.
Endoscopic treatment, particularly endoscopic submucosal dissection, has become the primary treatment for early gastric cancer. A comprehensive optical assessment, including white light endoscopy, image-enhanced endoscopy, and magnification...
Lucille Quénéhervé,Mathieu Pioche,Jérémie Jacques
Lucille Quénéhervé
As endoscopic treatment enables en bloc resection of T1 colorectal cancers, the risk of recurrence, often assimilated to the risk of lymph node metastases, must be assessed in order to offer patients an additional treatment if this risk is ...
Management of high risk T1 esophageal adenocarcinoma following endoscopic resection [0.03%]
内镜切除后高危T1期食管腺癌的治疗
Philippe Leclercq,Raf Bisschops,Jacques J G H M Bergman et al.
Philippe Leclercq et al.
High-risk T1 esophageal adenocarcinoma (HR-T1 EAC) is defined as T1 cancer, with one or more of the following histological criteria: submucosal invasion, poorly or undifferentiated cancer, and/or presence of lympho-vascular invasion. Esopha...
Daphne D&#x;Amato,Marco Carbone
Daphne D&#x;Amato
Autoimmune liver diseases (AILDs) are complex diseases with unknown causes and immune-mediated pathophysiology. In primary biliary cholangitis (PBC) and autoimmune hepatitis (AIH) disease modifying drugs are available which improve patient ...
Prognostic models in alcohol-related liver disease and alcohol-related hepatitis [0.03%]
与酒精相关性肝病和酒精性肝炎预后模型有关的文章
Jessica Ann Musto,Michael Ronan Lucey
Jessica Ann Musto
Alcohol-associated liver disease (ALD) and alcohol-associated hepatitis (AH) are dynamic disorders whose prognosis can be challenging to determine. A number of prognostic models have been developed to determine likelihood of death, when to ...
James Neuberger,Lorenzo Fuccio
James Neuberger
Peter Rimmer,Tariq Iqbal
Peter Rimmer
In the ideal world prognostication or predicting disease course in any chronic condition would allow the clinician to anticipate disease behaviour, providing crucial information for the patient and data regarding best use of resources. Prog...